Publication | Open Access

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design

VaccinationImmune EvasionTumor ImmunologyBreast OncologyCancer ImmunosurveillanceDanger SignalsImmunologyTherapeutic VaccineBreast CancerCancer VaccinesTumor AntigenVaccine DesignImmunotherapyMedicineRadiation OncologyTumor Microenvironment